Published in World J Hepatol on February 18, 2017
Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg (2008) 4.86
Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg (2009) 3.15
Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg (2006) 2.70
Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg (2006) 2.49
Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST. Ann Surg (2007) 2.30
The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer. Gynecol Oncol (2008) 1.81
Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J Am Coll Surg (1998) 1.79
Results of hepatic resection for sarcoma metastatic to liver. Ann Surg (2001) 1.75
An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg (2003) 1.71
Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol (2006) 1.70
Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery (1997) 1.68
Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann Surg (2005) 1.60
Hepatic resection of metastatic testicular carcinoma: a further update. Ann Surg Oncol (1999) 1.59
Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review. Ann Surg Oncol (2005) 1.59
Benefits and limits of hepatic resection for gastric metastases. Am J Surg (2001) 1.52
Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Ann Surg Oncol (2010) 1.50
A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer. HPB (Oxford) (2012) 1.45
Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. Ann Oncol (2008) 1.44
Long-term outcomes after surgical resection for gastric cancer liver metastasis: an analysis of 64 macroscopically complete resections. Langenbecks Arch Surg (2012) 1.28
Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver. Arch Surg (2006) 1.23
Hepatic metastases from leiomyosarcoma: A single-center experience with 34 liver resections during a 15-year period. Ann Surg (2000) 1.20
Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter? Cancer (2010) 1.14
Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol (2010) 1.14
Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis. J Am Coll Surg (2012) 1.14
Hepatic resection in metastatic breast cancer: results and prognostic factors. Eur J Surg Oncol (2000) 1.12
Surgical management of liver metastases from uveal melanoma: 16 years' experience at the Institut Curie. Eur J Surg Oncol (2009) 1.11
Liver resection for metastases from renal cell carcinoma. World J Surg (2007) 1.09
Long-term results of liver resection for non-colorectal, non-neuroendocrine metastases. Ann Surg Oncol (2007) 1.03
Hepatic resection for noncolorectal nonneuroendocrine metastases. World J Surg (1995) 1.02
Surgical treatment of renal cell cancer liver metastases: a population-based study. Ann Surg Oncol (2011) 1.02
Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era. Cancer (2011) 1.02
Gastric cancer and synchronous hepatic metastases: is it possible to recognize candidates to R0 resection? Ann Surg Oncol (2014) 1.01
Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study). Eur J Surg Oncol (2014) 0.97
Surgery including liver resection for metastatic gastrointestinal stromal tumors or gastrointestinal leiomyosarcomas. Jpn J Clin Oncol (2005) 0.96
Influence of Surgical Resection of Hepatic Metastases From Gastric Adenocarcinoma on Long-term Survival: Systematic Review and Pooled Analysis. Ann Surg (2016) 0.96
Hepatic Resection or Ablation for Isolated Breast Cancer Liver Metastasis: A Case-control Study With Comparison to Medically Treated Patients. Ann Surg (2016) 0.96
Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome. Surgery (2012) 0.94
Is there a role of surgery in patients with recurrent or metastatic gastrointestinal stromal tumours responding to imatinib: a prospective randomised trial in China. Eur J Cancer (2014) 0.94
Liver resection for multimodal treatment of breast cancer metastases: identification of prognostic factors. Ann Surg Oncol (2010) 0.94
Hepatic resection for metachronous metastases from ovarian carcinoma. Gynecol Oncol (2003) 0.94
Progression and survival results after radical hepatic metastasectomy of indolent advanced neuroendocrine neoplasms (NENs) supports an aggressive surgical approach. Surgery (2010) 0.94
Multicentre analysis of long-term outcome after surgical resection for gastric cancer liver metastases. Br J Surg (2014) 0.94
Liver metastases from breast cancer: Surgical resection or not? A case-matched control study in highly selected patients. Eur J Surg Oncol (2013) 0.92
Resection combined with imatinib therapy for liver metastases of gastrointestinal stromal tumors. Surg Today (2010) 0.91
Safety and efficacy of curative intent surgery for peri-ampullary liver metastasis. J Surg Oncol (2010) 0.86
Liver resection for metastatic soft tissue sarcoma: an analysis of prognostic factors. Eur J Surg Oncol (2011) 0.86
Liver resection for non-colorectal, non-neuroendocrine metastases: analysis of a multicenter study from Argentina. HPB (Oxford) (2007) 0.86
Repeat hepatectomy for recurrent liver metastasis from gastric carcinoma. World J Surg (2013) 0.85
Metastatic melanoma to the liver: a contemporary and comprehensive review of surgical, systemic, and regional therapeutic options. Cancer (2013) 0.84
The role of liver-directed surgery in patients with hepatic metastasis from a gynecologic primary carcinoma. World J Surg (2011) 0.82
Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302). Gastric Cancer (2015) 0.81
The role of liver resection at the time of secondary cytoreduction in patients with recurrent ovarian cancer. Int J Gynecol Cancer (2014) 0.81
Clinical benefit of surgical management for gastric cancer with synchronous liver metastasis. Hepatogastroenterology (2014) 0.80
Hepatic Resection is Safe for Metachronous Hepatic Metastases from Ovarian Cancer. Cancer Biol Med (2012) 0.80
Pattern of postoperative recurrence and hepatic and/or pulmonary resection for liver and/or lung metastases from esophageal carcinoma. World J Surg (2013) 0.79
Resection of liver metastases in patients with gastrointestinal stromal tumors in the imatinib era: A nationwide retrospective study. Eur J Surg Oncol (2016) 0.79
Long-term results of hepatic resection for non-colorectal, non-neuroendocrine liver metastasis. Hepatogastroenterology (2013) 0.78
Clinical outcome of patients with advanced ovarian cancer after resection of liver metastases. Anticancer Res (2012) 0.78
Liver resection for ovarian cancer liver metastases as part of cytoreductive surgery is safe and may bring survival benefit. World J Surg Oncol (2015) 0.77
Clinical Features of Surgical Resection for Liver Metastasis from Extremity Soft Tissue Sarcoma. Hepatogastroenterology (2015) 0.76
Liver Resection for Non-colorectal Non-neuroendocrine Metastases: Where Do We Stand Today Compared to Colorectal Cancer? J Gastrointest Surg (2016) 0.76
Radiofrequency ablation and surgical resection of liver metastases from uveal melanoma. Eur J Surg Oncol (2016) 0.76
Is Hepatic Resection for Non-colorectal, Non-neuroendocrine Liver Metastases Justified? Ann Surg Oncol (2015) 0.76